MedPath
NMPA Approval

Tafluprost Eye Drops

国药准字H20243590

April 24, 2024

Drug Information

他氟前列素滴眼液

眼用制剂

0.0015%(2.5ml: 37.5μg)

化学药品

April 24, 2024

Company Information

Applicant Company

浙江省金华市婺城区白汤下线高畈段58号X02幢办公质检楼二楼

Manufacturing Company

浙江省金华市工业园区金衢路368号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

他氟前列素滴眼液 - NMPA 批准文号 | MedPath